ETV4 Antikörper (AA 1-207)
Kurzübersicht für ETV4 Antikörper (AA 1-207) (ABIN560805)
Target
Alle ETV4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-207
-
Verwendungszweck
- Mouse monoclonal antibody raised against a full length recombinant ETV4.
-
Sequenz
- MYLHTEGFSG PSPGDGAMGY GYEKPLRPFP DDVCVAPEKF EGDIKQEGVG AFREGPPYQR RGALQLWQFL VALLDDPTNA HFIAWTGRGM EFKLIEPEEV ARLWGIQKNR PAMNYDKLSR SLRYYYEKGI MQKVAGERYV YKFVCEPEAL FSLAFPDNQR PALKAEFDRP VSEEDTVPLS HLDESPAYLP ELAGPAQPFG PKGGYSY
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- ETV4 (AAH07242, 1 a.a. ~ 207 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition." in: Oncogenesis, Vol. 1, pp. e20, (2013) (PubMed).
: "A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer." in: Cancer research, Vol. 68, Issue 18, pp. 7629-37, (2008) (PubMed).
-
: "Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition." in: Oncogenesis, Vol. 1, pp. e20, (2013) (PubMed).
-
- ETV4 (Ets Variant 4 (ETV4))
-
Andere Bezeichnung
- ETV4
-
Hintergrund
-
Full Gene Name: ets variant 4
Synonyms: E1A-F,E1AF,PEA3,PEAS3 -
Gen-ID
- 2118
Target
-